Insights into the GALAD score: A new optimal cut-off for hepatocellular carcinoma

doi:10.3748/wjg.v31.i40.111727

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 31, Issue 40

This Article

(54)

(76)

(0)

(1011)

(1)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Oct 28, 2025; 31(40): 111727
Published online Oct 28, 2025. doi: 10.3748/wjg.v31.i40.111727

Full Size Figure Download Figure

Figure 3 Area under curve (receiver operating characteristic) of GALAD score. A: Optimal cut-off for healthy and hepatocellular carcinoma subjects; B: Optimal cut-off for cirrhosis and hepatocellular carcinoma subjects. ROC: Receiver operating characteristic; PPV: Positive predictive value; NPV: Negative predictive value.

Citation: Villa E, Donghia R, Coletta S, Bonfiglio C, Critelli RM, Ancona A, Shahini E, Iacovazzi PA, Cozzolongo R, Pavone F, Carella N, Pontisso P, Martini A, Al Aoua S, Bantel H, Giannelli G. Insights into the GALAD score: A new optimal cut-off for hepatocellular carcinoma. World J Gastroenterol 2025; 31(40): 111727
URL: https://www.wjgnet.com/1007-9327/full/v31/i40/111727.htm
DOI: https://dx.doi.org/10.3748/wjg.v31.i40.111727

Villa E, Donghia R, Coletta S, Bonfiglio C, Critelli RM, Ancona A, Shahini E, Iacovazzi PA, Cozzolongo R, Pavone F, Carella N, Pontisso P, Martini A, Al Aoua S, Bantel H, Giannelli G. Insights into the GALAD score: A new optimal cut-off for hepatocellular carcinoma. World J Gastroenterol 2025; 31(40): 111727 [PMID: 41180985 DOI: 10.3748/wjg.v31.i40.111727]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.